Drugs & Therapy Perspectives

, Volume 19, Issue 6, pp 5–6 | Cite as

Ezetimibe: profile report

  • Harold Bays
  • Anthony S. Wierzbicki
Drugs and Profile Reports
  • 14 Downloads

Keywords

Statin Ezetimibe Bile Acid Sequestrant Statin Dose Cardiovasc Drug 

References

  1. 1.
    Darkes MJM, Poole RM, Goa KL. Ezetimibe. Am J Cardiovasc Drugs 2003; 3(1): 67–78PubMedCrossRefGoogle Scholar
  2. 2.
    Bays H. Ezetimibe: a viewpoint by Harold Bays. Am J Cardiovasc Drugs 2003; 3(1): 77CrossRefGoogle Scholar
  3. 3.
    Wierzbicki AS. Ezetimibe: a viewpoint by Anthony S. Wierzbicki. Am J Cardiovasc Drugs 2003; 3(1): 77CrossRefGoogle Scholar
  4. 4.
    Libby P. Atherosclerosis: the new view. Sci Am 2002; May: 29–37Google Scholar
  5. 5.
    Primatesta P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ 2000; 321: 1322–5PubMedCrossRefGoogle Scholar
  6. 6.
    van Heek M, Farley C, Compton DS, et al. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br J Pharmacol 2001; 134(2): 409–17PubMedCrossRefGoogle Scholar
  7. 7.
    Sudhop T, Von Bergmann K. Cholesterol absorption inhibitors for the treatment of hypercholesterolaemia. Drugs 2002; 62(16): 2333–47PubMedCrossRefGoogle Scholar
  8. 8.
    Davis HR, Compton DS, Hoos L, et al. Ezetimibe (SCH58235) localizes to the brush border of small intestinal enterocyte and inhibits entertocyte cholesterol uptake and absorption [abstract no. P3500]. Eur Heart J 2000 Aug; 21 (Abstr. Suppl.): 636Google Scholar
  9. 9.
    Dujovne CA, Ettinger MP, McNeer JF, et al. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol 2002 Nov 15; 90: 1092–7PubMedCrossRefGoogle Scholar
  10. 10.
    Knopp RH, Gitter H, Truitt T, et al. Ezetimibe reduces low-density lipoprotein cholesterol: results of a phase III, randomized, double-blind, placebo-controlled trial [abstract no. W6.2]. Atherosclerosis Suppl 2001 May; 2(2): 38CrossRefGoogle Scholar
  11. 11.
    Davidson M, McGarry T, Bettis R, et al. Ezetimibe co-administered with simvastatin in patients with primary hypercholesterolemia. J Am Coll Cardiol 2002 Dec 18; 40(12): 2125–34PubMedCrossRefGoogle Scholar
  12. 12.
    Lipka L, Kerzner B, Corbelli J, et al. Results of ezetimibe co-administered with lovastatin in 548 patients with primary hypercholesterolemia [abstract]. J Am Coll Cardiol 2002 May 1; 39 Suppl.B:430BGoogle Scholar
  13. 13.
    Melani L, Mills R, Hassman D, et al. Ezetimibe co-administered with pravastatin in 538 patients with primary hypercholesterolemia [abstract]. J Am Coll Cardiol 2002 May 1; 39 Suppl. B: 134–135 (plus poster presented at the XIV World Congress of Cardiology, 2002 May, Sydney)Google Scholar
  14. 14.
    Ballantyne C, Houri J, Notarbartolo A, et al. Ezetimibe co-administered with atorvastatin in 628 patients with primary hypercholesterolemia [abstract]. J Am Coll Cardiol 2002 May 1; 39 Suppl. B: 135–136 (plus poster presented at the XIV World Congress of Cardiology, 2002 May, Sydney)Google Scholar
  15. 15.
    Gagné C, Bays HE, Weiss SR, et al. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardio 2002; 90 (15 Nov): 1084–91CrossRefGoogle Scholar
  16. 16.
    Gagné C, Gaudet D, Bruckert E. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. Ezetimibe Study Group. Circulation 2002; 105(21): 2469–75PubMedCrossRefGoogle Scholar
  17. 17.
    Salen G, von Bergmann K, Kwiterovich P, et al. Ezetimbe is an effective treatment for homozygous sitosterolemia [abstract no. 929]. American Heart Association 75th Scientific Sessions 2002 Nov 17–20, Orlando, FloridaGoogle Scholar
  18. 18.
    Bays HE, Moore PB, Drehobl MA, et al. Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clin Ther 2001 Aug; 23(8): 1209–30PubMedCrossRefGoogle Scholar
  19. 19.
    Bays HE. Ezetimibe. Expert Opin Investig Drugs 2002; 11(11): 1587–604PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2003

Authors and Affiliations

  • Harold Bays
    • 1
  • Anthony S. Wierzbicki
    • 2
  1. 1.Louisville Metabolic and Atherosclerosis Research CenterLouisvilleUSA
  2. 2.Department of Chemical PathologySt Thomas’ HospitalLondonEngland

Personalised recommendations